APOA2 anticorps (FITC)

N° du produit ABIN7454056

L’anticorps Chèvre Polyclonal anti-APOA2 a été validé pour . Il convient pour détecter APOA2 dans des échantillons de Humain.

Aperçu rapide pour APOA2 anticorps (FITC) (ABIN7454056)

Antigène: APOA2 (Apolipoprotein A-II (APOA2))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp APOA2 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Clone: F04

Détail du produit anti-APOA2 anticorps (FITC)

Fonction: Goat anti-Human Apo AII [F04] Antibody FITC Conjugated

Immunogène: Human Apolipoprotein AII

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur APOA2

Antigène: APOA2 (Apolipoprotein A-II (APOA2))

Autre désignation: ApoAII

Sujet: Background: Apo AII comprises 25 % of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993), however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events. (Birjmohun et al., 2007)

ID gène: 336

NCBI Accession: NP_001634

UniProt: P02652

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism